Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells

Chronic myeloid leukemia (CML) is a hematologic disorder characterized by the oncogene BCR-ABL1, which encodes an oncoprotein with tyrosine kinase activity. Imatinib, a BCR-ABL1 tyrosine kinase inhibitor, performs exceptionally well with minimal toxicity in CML chemotherapy. According to clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Prado-Carrillo, Omar, Arenas-Ramírez, Abner, Llaguno-Munive, Monserrat, Jurado, Rafael, Pérez-Rojas, Jazmin, Cervera-Ceballos, Eduardo, Garcia-Lopez, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317189/
https://www.ncbi.nlm.nih.gov/pubmed/35887063
http://dx.doi.org/10.3390/ijms23147715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317189/
https://www.ncbi.nlm.nih.gov/pubmed/35887063
http://dx.doi.org/10.3390/ijms23147715

Ejemplares similares